304 related articles for article (PubMed ID: 22072272)
21. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy.
Wong RK; Jones GW; Sagar SM; Babjak AF; Whelan T
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):472-80. PubMed ID: 12957259
[TBL] [Abstract][Full Text] [Related]
22. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
24. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
[TBL] [Abstract][Full Text] [Related]
25. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: A randomized controlled clinical trial.
Louzeiro GC; Cherubini K; de Figueiredo MAZ; Salum FG
J Photochem Photobiol B; 2020 Aug; 209():111933. PubMed ID: 32570059
[TBL] [Abstract][Full Text] [Related]
26. The effect of acupuncture on salivary flow rates in patients with radiation-induced xerostomia.
Braga FP; Sugaya NN; Hirota SK; Weinfeld I; Magalhães MH; Migliari DA
Minerva Stomatol; 2008; 57(7-8):343-8. PubMed ID: 18784633
[TBL] [Abstract][Full Text] [Related]
27. Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma.
Pow EH; McMillan AS; Leung WK; Wong MC; Kwong DL
Clin Oral Investig; 2003 Dec; 7(4):230-4. PubMed ID: 12955605
[TBL] [Abstract][Full Text] [Related]
28. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis.
Sood AJ; Fox NF; O'Connell BP; Lovelace TL; Nguyen SA; Sharma AK; Hornig JD; Day TA
Oral Oncol; 2014 Feb; 50(2):77-83. PubMed ID: 24189058
[TBL] [Abstract][Full Text] [Related]
29. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
30. Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer.
Marucci L; Marzi S; Sperduti I; Giovinazzo G; Pinnarò P; Benassi M; Strigari L
Head Neck; 2012 Mar; 34(3):328-35. PubMed ID: 21400632
[TBL] [Abstract][Full Text] [Related]
31. Effects of an integrated supportive program on xerostomia and saliva characteristics in patients with head and neck cancer radiated with a low dose to the major salivary glands: a randomized controlled trial.
Jiang N; Zhao Y; Stensson M; Mårtensson J
BMC Oral Health; 2022 May; 22(1):199. PubMed ID: 35606811
[TBL] [Abstract][Full Text] [Related]
32. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients.
Malouf JG; Aragon C; Henson BS; Eisbruch A; Ship JA
Cancer Detect Prev; 2003; 27(4):305-10. PubMed ID: 12893079
[TBL] [Abstract][Full Text] [Related]
33. ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer.
Simcock R; Fallowfield L; Monson K; Solis-Trapala I; Parlour L; Langridge C; Jenkins V;
Ann Oncol; 2013 Mar; 24(3):776-83. PubMed ID: 23104718
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of the pilocarpine test to identify patients who may obtain long-term relief from xerostomia by acupuncture treatment.
Blom M; Kopp S; Lundeberg T
Arch Otolaryngol Head Neck Surg; 1999 May; 125(5):561-6. PubMed ID: 10326815
[TBL] [Abstract][Full Text] [Related]
36. The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients.
Zhao D; Fan W; Jiang H; Meng L; Cai B; Zhang X; Yu W; Zhao L; Ma L
Strahlenther Onkol; 2024 May; 200(5):377-388. PubMed ID: 37955647
[TBL] [Abstract][Full Text] [Related]
37. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
[TBL] [Abstract][Full Text] [Related]
38. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
Jen YM; Lin YC; Wang YB; Wu DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):322-7. PubMed ID: 16504865
[TBL] [Abstract][Full Text] [Related]
39. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
